Navigation Links
New Delhi metallo-beta-lactamase-1 enzyme acquired in Canada

An enzyme associated with extensive antibiotic resistance called New Delhi metallo--lactamase-1 (NDM-1), endemic in India and Pakistan and spreading worldwide, has been found in two people in the Toronto area, one of whom acquired it in Canada, states a case report in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) The report outlines challenges and approaches to managing and identifying this pathogen, which is highly resistant to treatment.

NDM-1 has spread because of worldwide travel, medical tourism and its ability to transfer between bacteria.

In one of the cases in this report, the patient had not travelled outside southwestern Ontario in over a decade, and no source could be identified for the organism. In the other case, the patient had been hospitalized in India for a medical procedure and acquired the organism there.

"These two scenarios show that local acquisition of an organism producing NDM-1 has already occurred in Ontario, Canada, that blaNDM-1 has been found in bacterial species other than [Escherichia coli] and [Klebsiella pneumoniae], that treatment options are limited for infections with NDM-1-producing organisms, and that the detection of NDM-1-producing organisms by a laboratory can be difficult," writes Dr. Susan Poutanen, Mount Sinai Hospital and University Health Network, with coauthors.

In the case of the patient who had not travelled, the authors note: "To the best of our knowledge, this is the first reported instance in which an NDM-1-producing organism was locally acquired in Canada."

In cases where patients are infected with NDM-1, extensive infection control precautions must be taken, including isolation in single rooms and enhanced cleaning.

"European guidelines recommend even more precautionary approaches to protecting patients admitted to hospital and suggest that all hospitals should have preparedness plans in place," state the authors.

Laboratory detection of the pathogen is also difficult, and labs should adopt different screening procedures.


Contact: Kim Barnhardt
613-520-7116 x2224
Canadian Medical Association Journal

Related medicine news :

1. Delhi air quality regulations improve respiratory health
2. Enzyme may drive breast cancer growth
3. Study suggests enzyme crucial to DNA replication may provide potent anti-cancer drug target
4. The TET1 enzyme steers us through fetal development and fights cancer
5. Investigators discover enzyme essential for healthy lung development
6. Newly discovered role for enzyme in neurodegenerative diseases
7. Enzyme helps prepare lung tissue for metastatic development
8. Heart Enzymes May Predict Outcome After Bypass Surgery
9. Breathing easy: LSU biochemists offer first 3-D model of asthma-causing inflammation enzyme
10. Princess Margaret Hospital researchers identify a key enzyme that affects radiation response
11. Chaperone enzyme provides new target for cancer treatments
Post Your Comments:
(Date:11/25/2015)... ... ... “While riding the bus, I saw a passenger in a wheelchair drenched from ... a convenient and comfortable way to protect them from bad weather, so I invented ... during cold or inclement weather. In doing so, it ensures that the user remains ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... An unlikely combination ... in a way for homeless people to have a more dignified and comfortable ... initiative whereby they are repurposing plastic bags into sleeping mats for the homeless. ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... focused on providing comprehensive solutions involving adult stem cell therapies to patients with ... deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are required ...
(Date:11/24/2015)... ... 2015 , ... Genesis Chiropractic Software helps practice owners automate ... between the practice owner and the patient that automatically manages all five aspects ... Click here to learn more. , According to Dr. Brian ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
Breaking Medicine Technology: